| 0 |
APPLICATION SITE VESICLES |
78 |
| 1 |
APPLICATION SITE PAIN |
53 |
| 2 |
BLISTER |
30 |
| 3 |
PAIN |
16 |
| 4 |
APPLICATION SITE BURN |
12 |
| 5 |
BLISTER RUPTURE |
8 |
| 6 |
HYPERSENSITIVITY |
8 |
| 7 |
APPLICATION SITE ERYTHEMA |
7 |
| 8 |
DRUG INEFFECTIVE |
7 |
| 9 |
ACCIDENTAL EXPOSURE TO PRODUCT |
6 |
| 10 |
CHEMICAL BURN |
6 |
| 11 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
| 12 |
BLOOD BLISTER |
5 |
| 13 |
PRODUCT USE ISSUE |
5 |
| 14 |
PYREXIA |
5 |
| 15 |
SKIN EXFOLIATION |
5 |
| 16 |
ACUTE KIDNEY INJURY |
4 |
| 17 |
APPLICATION SITE INFECTION |
4 |
| 18 |
APPLICATION SITE PRURITUS |
4 |
| 19 |
APPLICATION SITE REACTION |
4 |
| 20 |
OFF LABEL USE |
4 |
| 21 |
PRODUCT ADMINISTERED BY WRONG PERSON |
4 |
| 22 |
APPLICATION SITE DISCOLOURATION |
3 |
| 23 |
APPLICATION SITE DISCOMFORT |
3 |
| 24 |
APPLICATION SITE HAEMORRHAGE |
3 |
| 25 |
CRYING |
3 |
| 26 |
FATIGUE |
3 |
| 27 |
GAIT DISTURBANCE |
3 |
| 28 |
HYPERURICAEMIA |
3 |
| 29 |
IMPETIGO |
3 |
| 30 |
LETHARGY |
3 |
| 31 |
NAUSEA |
3 |
| 32 |
PRODUCT DELIVERY MECHANISM ISSUE |
3 |
| 33 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
3 |
| 34 |
THERMAL BURN |
3 |
| 35 |
URTICARIA |
3 |
| 36 |
WOUND |
3 |
| 37 |
ABDOMINAL PAIN |
2 |
| 38 |
ADVERSE DRUG REACTION |
2 |
| 39 |
APPLICATION SITE EROSION |
2 |
| 40 |
APPLICATION SITE IRRITATION |
2 |
| 41 |
APPLICATION SITE SCAB |
2 |
| 42 |
APPLICATION SITE SCAR |
2 |
| 43 |
BURNING SENSATION |
2 |
| 44 |
DIARRHOEA |
2 |
| 45 |
DISCOMFORT |
2 |
| 46 |
DRUG INTERACTION |
2 |
| 47 |
DRUG RESISTANCE |
2 |
| 48 |
EXTRA DOSE ADMINISTERED |
2 |
| 49 |
HAEMORRHAGE |
2 |
| 50 |
HYPERCHOLESTEROLAEMIA |
2 |
| 51 |
INFECTION |
2 |
| 52 |
INJURY ASSOCIATED WITH DEVICE |
2 |
| 53 |
LIP BLISTER |
2 |
| 54 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
| 55 |
LOSS OF CONSCIOUSNESS |
2 |
| 56 |
MALAISE |
2 |
| 57 |
MUSCLE RIGIDITY |
2 |
| 58 |
POST PROCEDURAL COMPLICATION |
2 |
| 59 |
PRODUCT COMMUNICATION ISSUE |
2 |
| 60 |
PRODUCT PACKAGE ASSOCIATED INJURY |
2 |
| 61 |
PRODUCT PRESCRIBING ERROR |
2 |
| 62 |
RASH |
2 |
| 63 |
RENAL IMPAIRMENT |
2 |
| 64 |
SCREAMING |
2 |
| 65 |
SKIN DISORDER |
2 |
| 66 |
SKIN LACERATION |
2 |
| 67 |
SKIN REACTION |
2 |
| 68 |
SKIN TIGHTNESS |
2 |
| 69 |
TREATMENT FAILURE |
2 |
| 70 |
VOMITING |
2 |
| 71 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
| 72 |
ADVERSE EVENT |
1 |
| 73 |
ANAEMIA |
1 |
| 74 |
ANAL INCONTINENCE |
1 |
| 75 |
ANOGENITAL WARTS |
1 |
| 76 |
APPLICATION SITE DISCHARGE |
1 |
| 77 |
APPLICATION SITE EXFOLIATION |
1 |
| 78 |
APPLICATION SITE INFLAMMATION |
1 |
| 79 |
APPLICATION SITE PAPULES |
1 |
| 80 |
APPLICATION SITE PLAQUE |
1 |
| 81 |
APPLICATION SITE RASH |
1 |
| 82 |
APPLICATION SITE URTICARIA |
1 |
| 83 |
APPLICATION SITE WARMTH |
1 |
| 84 |
APPLICATION SITE WOUND |
1 |
| 85 |
BACTERIAL INFECTION |
1 |
| 86 |
BLISTER INFECTED |
1 |
| 87 |
BURNS SECOND DEGREE |
1 |
| 88 |
CHEMICAL BURNS OF EYE |
1 |
| 89 |
CHEST DISCOMFORT |
1 |
| 90 |
CIRCULATORY COLLAPSE |
1 |
| 91 |
CONDITION AGGRAVATED |
1 |
| 92 |
CONFUSIONAL STATE |
1 |
| 93 |
CORNEAL ABRASION |
1 |
| 94 |
COUGH |
1 |
| 95 |
COVID-19 |
1 |
| 96 |
CRYOTHERAPY |
1 |
| 97 |
DEVICE BREAKAGE |
1 |
| 98 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
| 99 |
DISEASE PROGRESSION |
1 |
| 100 |
DISEASE RECURRENCE |
1 |
| 101 |
DISORIENTATION |
1 |
| 102 |
DIZZINESS |
1 |
| 103 |
DRUG HYPERSENSITIVITY |
1 |
| 104 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 105 |
DRUG INTOLERANCE |
1 |
| 106 |
DRUG LEVEL FLUCTUATING |
1 |
| 107 |
DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED |
1 |
| 108 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
| 109 |
DRY MOUTH |
1 |
| 110 |
DYSPNOEA |
1 |
| 111 |
DYSPNOEA EXERTIONAL |
1 |
| 112 |
ECZEMA |
1 |
| 113 |
EFFUSION |
1 |
| 114 |
EPSTEIN-BARR VIRAEMIA |
1 |
| 115 |
ERYSIPELAS |
1 |
| 116 |
ERYTHEMA |
1 |
| 117 |
FLUID INTAKE REDUCED |
1 |
| 118 |
FURUNCLE |
1 |
| 119 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
| 120 |
INABILITY TO AFFORD MEDICATION |
1 |
| 121 |
INCREASED DOSE ADMINISTERED |
1 |
| 122 |
KIDNEY TRANSPLANT REJECTION |
1 |
| 123 |
LYMPHADENOPATHY |
1 |
| 124 |
MUCOSAL INFECTION |
1 |
| 125 |
NASOPHARYNGITIS |
1 |
| 126 |
NO THERAPEUTIC RESPONSE |
1 |
| 127 |
NON-CARDIAC CHEST PAIN |
1 |
| 128 |
ORAL MUCOSAL BLISTERING |
1 |
| 129 |
OROPHARYNGEAL PAIN |
1 |
| 130 |
OVERDOSE |
1 |
| 131 |
PAIN IN JAW |
1 |
| 132 |
PAIN OF SKIN |
1 |
| 133 |
PARAESTHESIA |
1 |
| 134 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
| 135 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
| 136 |
PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER |
1 |
| 137 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
| 138 |
PRODUCT COLOUR ISSUE |
1 |
| 139 |
PRODUCT DISTRIBUTION ISSUE |
1 |
| 140 |
PRODUCT DOSE OMISSION ISSUE |
1 |
| 141 |
PRODUCT KNOWLEDGE DEFICIT |
1 |
| 142 |
PRODUCT LABEL ISSUE |
1 |
| 143 |
PRODUCT PACKAGING QUANTITY ISSUE |
1 |
| 144 |
PRODUCT QUALITY ISSUE |
1 |
| 145 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 146 |
RASH ERYTHEMATOUS |
1 |
| 147 |
RENAL DISORDER |
1 |
| 148 |
RENAL TUBULAR DISORDER |
1 |
| 149 |
SCAB |
1 |
| 150 |
SCAR |
1 |
| 151 |
SCRATCH |
1 |
| 152 |
SECRETION DISCHARGE |
1 |
| 153 |
SEIZURE |
1 |
| 154 |
SKIN ABRASION |
1 |
| 155 |
SKIN BACTERIAL INFECTION |
1 |
| 156 |
SKIN EROSION |
1 |
| 157 |
SKIN FISSURES |
1 |
| 158 |
SKIN INFECTION |
1 |
| 159 |
SKIN INJURY |
1 |
| 160 |
SKIN PAPILLOMA |
1 |
| 161 |
SKIN PLAQUE |
1 |
| 162 |
SKIN TEMPERATURE INCREASED |
1 |
| 163 |
STAPHYLOCOCCAL SKIN INFECTION |
1 |
| 164 |
SUPERINFECTION |
1 |
| 165 |
SWELLING OF EYELID |
1 |
| 166 |
SYNCOPE |
1 |
| 167 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
| 168 |
THERAPY NON-RESPONDER |
1 |
| 169 |
THINKING ABNORMAL |
1 |
| 170 |
TREATMENT DELAYED |
1 |
| 171 |
ULNA FRACTURE |
1 |
| 172 |
URINARY BLADDER RUPTURE |
1 |
| 173 |
VULVOVAGINAL PAIN |
1 |